Trial record 2 of 442 for:    translate

to Translate and Validate the TOPAS TORONTO PSORIATIC SCREENING QUESTIONNAIRE)Into Spanish (spanishTopas)

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2013 by Reumatologia Integral LTDA
Sponsor:
Information provided by (Responsible Party):
Adriana Beltran, Reumatologia Integral LTDA
ClinicalTrials.gov Identifier:
NCT01891903
First received: June 18, 2013
Last updated: June 28, 2013
Last verified: June 2013
  Purpose

TO TRANSALETE AND VALIDATE DE TORONTO PSORIATIC ARTHRITIS SECREENING QUESTIONAIRE INTO SPANISH


Condition
Psoriatic Arthritis

Study Type: Observational [Patient Registry]
Study Design: Time Perspective: Prospective
Target Follow-Up Duration: 20 Days
Official Title: TO TRANSLATE AND VALIDATE THE ToPAS (TORONTO PSORIATIC SCREENING QUESTIONNAIRE) FOR THE SCREENING OF PSORIATHIC ARTHRITIS PATIENTS IN DERMATOLOGY CLINICS

Resource links provided by NLM:


Further study details as provided by Reumatologia Integral LTDA:

Primary Outcome Measures:
  • The Kuder Richardson Coefficient of reliability (K-R 20) [ Time Frame: 4 MONTHS ] [ Designated as safety issue: No ]

Estimated Enrollment: 60
Study Start Date: May 2013
Estimated Study Completion Date: September 2013
Estimated Primary Completion Date: August 2013 (Final data collection date for primary outcome measure)
Detailed Description:

THIS IS PART OF THE COLOMBIAN REGISTRY OF PATIENTS WITH PSORIASIS AND PSORIATIC ARTHRITIS

  Eligibility

Ages Eligible for Study:   16 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

PATIENTS WITH PSORIASIS ASESSED IN THE DERMATOLOGY CLINIC

Criteria

Inclusion Criteria:

  • ADULT WITH PSORIASIS IN THE DERMATOLOGY CLINIC

Exclusion Criteria:

  • ADULT WITH OTHER AUTOIMMUNE DISEASE
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01891903

Locations
Colombia
Hospital Universitario Clinica San Rafael Recruiting
Bogota, Cundinamarca, Colombia, 12345
Contact: ADRIANA BELTRAN, RHEUMATOL    0573134327730    adribeltr@yahoo.com   
Sponsors and Collaborators
Reumatologia Integral LTDA
Investigators
Study Director: Daniel Fernandez, rheumatolo hospital san ignasio
  More Information

No publications provided

Responsible Party: Adriana Beltran, ADRIANA BELTRAN OSTOS, Reumatologia Integral LTDA
ClinicalTrials.gov Identifier: NCT01891903     History of Changes
Other Study ID Numbers: TOPAS52424166
Study First Received: June 18, 2013
Last Updated: June 28, 2013
Health Authority: Colombia: Ethics Committee

ClinicalTrials.gov processed this record on March 31, 2015